Age, Biography and Wiki
Gonçalo Abecasis (Gonçalo Rocha Abecasis) was born on 8 May, 1976 in Michigan. Discover Gonçalo Abecasis's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 47 years old?
| Popular As |
Gonçalo Rocha Abecasis |
| Occupation |
N/A |
| Age |
48 years old |
| Zodiac Sign |
Taurus |
| Born |
8 May 1976 |
| Birthday |
8 May |
| Birthplace |
N/A |
| Nationality |
United States |
We recommend you to check the complete list of Famous People born on 8 May.
He is a member of famous with the age 48 years old group.
Gonçalo Abecasis Height, Weight & Measurements
At 48 years old, Gonçalo Abecasis height not available right now. We will update Gonçalo Abecasis's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Who Is Gonçalo Abecasis's Wife?
His wife is Cristen Willer
| Family |
| Parents |
Not Available |
| Wife |
Cristen Willer |
| Sibling |
Not Available |
| Children |
5 |
Gonçalo Abecasis Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Gonçalo Abecasis worth at the age of 48 years old? Gonçalo Abecasis’s income source is mostly from being a successful . He is from United States. We have estimated
Gonçalo Abecasis's net worth
, money, salary, income, and assets.
| Net Worth in 2023 |
$1 Million - $5 Million |
| Salary in 2023 |
Under Review |
| Net Worth in 2022 |
Pending |
| Salary in 2022 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Gonçalo Abecasis Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
His published work is influential - as of 2018, he had an h-index of 145 and 144,018 citations. Thomson Reuters noted that he had 10 'hot papers' (in the top 0.1% by citations) in 2009. He was also noted for his 'hot papers' in 2011 and 2012.
In October 2014, he was awarded the Curt Stern Award in Human Genetics by the American Society of Human Genetics (jointly with Mark J. Daly).
He was elected to the Institute of Medicine in October 2014.
Abecasis won an Excellence in Research Award from the University of Michigan School of Public Health in 2008, and he became a professor at the University of Michigan in 2009. He won the 2013 Overton Prize from the International Society for Computational Biology, giving a keynote speech at the ISMB, and was named a Pew Scholar by the Pew Charitable Trusts in 2005. His work was cited in 2010 by US Vice-President Joe Biden in a speech on the importance of biomedical research regarding the Recovery Act Innovation Report.
Abecasis works on statistical and computational approaches to human genetic disease, including psoriasis and cardiovascular diseases. His group develops tools to analyze and visualize biomedical data, often using C++. He first applied his programming knowledge during his Ph.D. studies to develop tools to analyze the data on asthma susceptibility that his project was generating. He continued as a biostatistician when he moved to Michigan in 2001, where he was recruited and mentored by Michael Boehnke. He is a proponent of data sharing. His work has included the 1000 Genomes Project and a collaboration with Oxford researchers.
Abecasis is the oldest of 12 children in his family, born in Moura to José Manuel and Maria Teresa. He grew up in Portugal and Macau (then Portuguese Macau). After learning computer programming in a high school club, he received a Bachelor of Science degree in Genetics from the University of Leeds in 1997, working with Mary Anne Shaw, and a D. Phil in human genetics from the University of Oxford in 2001, working with William Cookson and Lon Cardon.
Gonçalo Rocha Abecasis (born 1976) is a Portuguese American biomedical researcher at the University of Michigan and was chair of the Department of Biostatistics in the School of Public Health. He leads a group at the Center for Statistical Genetics in the Department of Biostatistics, where he is also the Felix E. Moore Collegiate Professor of Biostatistics and director of the Michigan Genomic Initiative. His group develops statistical tools to analyze the genetics of human disease.
